Search clinical trials for: Lenograstim

Total 483 results

WiSP Wissenschaftlicher Service Pharma GmbH
Ludwig-Maximilians - University of Munich; Chugai Pharma GmbH

Completed

Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy (CU01)

Hodgkin's Disease | Non-Hodgkin Lymphomas | Multiple Myelomas
DERSHENG SUN

Unknown

Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

Neutropenia

Korea, Republic of
University of Pisa

Unknown

Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim
Asan Medical Center

Unknown

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Multiple Myeloma

Korea, Republic of
Sanofi

Completed

A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen (Grano-Tax)

Neoplasms (no Otherwise Specified)

South Africa
Chang Gung Memorial Hospital

Recruiting

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Neutropenia | Pediatric Cancer | G-CSF | Lenograstim | Filgrastim

Taiwan
Deutsches Herzzentrum Muenchen
Else Kröner Fresenius Foundation; Wilhelm Sander Foundation; Schulz Foundation

Completed

Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)

Myocardial Infarction

Germany
Barts & The London NHS Trust
University College London Hospitals; Royal Brompton & Harefield NHS Foundation...

Completed

Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGEN-DCM)

Dilated Cardiomyopathy

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Stem Cells and Filgrastim

HIV Infections

United States
Azidus Brasil

Completed

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.

Healthy Subjects

Brazil
Azienda Ospedaliera San Giovanni Battista

Unknown

Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

Blood Diseases

Italy
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission

Leukemia

United States
Centre Francois Baclesse

Completed

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Breast Cancer | Neutropenia | Chemotherapeutic Agent Toxicity

France
The Cleveland Clinic

Completed

A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction

Acute Myocardial Infarction

United States
Amgen

Completed

Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors

Normal PBPC Donors
Centre National de Greffe de Moelle Osseuse

Unknown

Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation

Graft vs Host Disease

Tunisia
National Center for Research Resources (NCRR)
James Whitcomb Riley Hospital for Children

Completed

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Thrombocytopenia | Dyskeratosis Congenita | Fanconi's Anemia | Shwachman Syndrome
Amgen

Completed

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

HIV Infections | Cytopenias

United States, Canada
CellProthera

Recruiting

Donation of Whole Blood by Healthy Volunteers After Mobilisation by Haematopoietic Growth Factor (Rhu-G-CSF = Granocyte) (CARDIOSTEM)

Healthy Volunteers

France
Anglo Celtic Cooperative Oncology Group
Scottish Cancer Therapy Network

Unknown

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

Breast Cancer | Neutropenia

United Kingdom
Amgen

Completed

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

Myeloid Leukemia
University of Colorado, Denver
Karsh Family Research Fund

Active, not recruiting

Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer

Head and Neck Cancer | Malignant Melanoma

United States
Clinique Ovo

Terminated

Gcsf Injection in Women With Repeated Implantaiton Failure

Repeated Embryo Implantation Failure

Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Solid Tumors
Amgen

Completed

A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

Neutropenia

United States, Bulgaria, Croatia, Hungary, Poland, Romania, Russian Federation, Ukraine
Tianjin SinoBiotech Ltd.

Completed

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Cancer, Breast | Chemotherapy-induced Neutropenia

China
Rabin Medical Center

Terminated

SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients (G-CSF)

Leukemia

Israel
Sandoz

Completed

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim (PIONEER)

Breast Cancer | Chemotherapy Associated Neutropenia

Czech Republic, Hungary, Latvia, Russian Federation, Slovakia, Ukraine
Clinical Institute of the Brain, Russia
City Hospital No 40, Saint Petersburg, Russia; Institute of Medical Cells Technologies

Completed

Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke (STEMTHER)

Ischemic Stroke

Russian Federation
Amgen

Completed

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Sarcoma | Neutropenia
Andrews Research & Education Foundation
Auburn University; Arthrex, Inc.

Completed

Stem Cells After Peripheral Mobilization and Harvest

Orthopedic Disorder | Stem Cells

United States
University Hospital Inselspital, Berne
Swiss National Science Foundation; Swiss Heart Foundation

Completed

Filgrastim for the Promotion of Collateral Growth in Patients With CAD

Coronary Artery Disease

Switzerland
University of Padova

Completed

Bone Marrow Progenitor Cell Mobilization in Diabetes (GCSF-DM)

Diabetes Mellitus

Italy
National Cancer Institute (NCI)

Completed

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

Neutropenia | Unspecified Adult Solid Tumor, Protocol Specific

United States
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Alberta Health services

Completed

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Peripheral Stem Cell/Marrow Transplant

Canada
University Hospital, Strasbourg, France

Completed

Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF

Neutropenia in Prematures

France
Recardio, Inc.

Not yet recruiting

Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction (HEAL-MI)

ST Elevation Myocardial Infarction
M.D. Anderson Cancer Center
Amgen

Terminated

Tissue Repair in Stem Cell Transplant Recipients

Graft-Versus-Host Disease

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI); Children's Hospital of Michigan

Terminated

Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Osteosarcoma | Neuroblastoma | Retinoblastoma | Recurrent/Refractory Childhood Hodgkin Lymphoma | Wilms Tumor and Other Childhood Kidney Tumors | Childhood Choroid Plexus Tumor | Childhood Soft Tissue Sarcoma | Childhood Medulloblastoma | Childhood... and other conditions

United States
Cinnagen

Completed

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Chemotherapy-induced Neutropenia
National Cancer Institute (NCI)

Completed

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

Rhabdomyosarcoma | Synovial Sarcoma | Ewing's Sarcoma | MPNST | High-risk Sarcoma

United States
Sir Ganga Ram Hospital

Completed

To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis

Cirrhosis

India
Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Recruiting

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

Healthy

United States
Ottawa Hospital Research Institute

Active, not recruiting

A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy

Early-stage Breast Cancer

Canada
Yale University
National Cancer Institute (NCI)

Completed

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Lymphoma

United States
Armando Santoro, MD

Completed

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Tumors | Hematological Neoplasms

Italy
AviGenics

Completed

Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

Breast Cancer | Neutropenia

United States, India
Emory University

Completed

Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)

Hematologic Diseases | Hematologic Malignancies

United States

3

Subscribe